[Federal Register Volume 74, Number 16 (Tuesday, January 27, 2009)]
[Notices]
[Page 4752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-1690]



[[Page 4752]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Autism Therapy Evaluation Effects of 
Hyperbaric Oxygen Therapy on Children with Autism, Request For 
Application (RFA), DD8EM-801.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:
    Time and Date: 1:30 p.m.-3 p.m., January 29, 2009 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of an application received in response to 
``Autism Therapy Evaluation Effects of Hyperbaric Oxygen Therapy on 
Children with Autism, RFA DD8EM-801.''
    This Federal Register notice is being published less than fifteen 
days prior to the meeting date, due to the decision of the National 
Center for Chronic Disease Prevention and Health Promotion to allow a 
deliberative discussion on this application.
    Contact Person for More Information: Brenda Colley Gilbert, Ph.D., 
Scientific Review Administrator, 2877 Brandywine Road, Atlanta, Georgia 
30341, telephone: (770) 488-8390.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

Lorenzo J. Falgiano,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E9-1690 Filed 1-26-09; 8:45 am]
BILLING CODE 4163-18-P